{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:57:20Z","timestamp":1791341840367,"version":"4.3.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T00:00:00Z","timestamp":1684022400000},"content-version":"am","delay-in-days":286,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ajem.2022.05.013","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T22:06:41Z","timestamp":1652479601000},"page":"22-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Buprenorphine precipitated opioid withdrawal: Prevention and management in the ED setting"],"prefix":"10.1016","volume":"58","author":[{"given":"Anthony","family":"Spadaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brit","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Koyfman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanmarie","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2\u20133","key":"10.1016\/j.ajem.2022.05.013_bb0005","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.drugalcdep.2006.06.014","article-title":"Evaluation of the use of buprenorphine for opioid withdrawal in an emergency department","volume":"86","author":"Berg","year":"2007","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.ajem.2022.05.013_bb0010","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ajem.2018.10.013","article-title":"Approach to buprenorphine use for opioid withdrawal treatment in the emergency setting","volume":"37","author":"Cisewski","year":"2019","journal-title":"Am J Emerg Med"},{"issue":"3","key":"10.1016\/j.ajem.2022.05.013_bb0015","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study","volume":"169","author":"Larochelle","year":"2018","journal-title":"Ann Intern Med"},{"issue":"16","key":"10.1016\/j.ajem.2022.05.013_bb0020","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jama.2015.3474","article-title":"Emergency department-initiated buprenorphine\/naloxone treatment for opioid dependence: a randomized clinical trial","volume":"313","author":"D\u2019Onofrio","year":"2015","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ajem.2022.05.013_bb0025","article-title":"Emergency department-initiated buprenorphine protocols: A national evaluation","volume":"2","author":"Guo","year":"2021","journal-title":"J Am Coll Emerg Phys Open"},{"key":"10.1016\/j.ajem.2022.05.013_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108410","article-title":"Bridge clinic buprenorphine program decreases emergency department visits","volume":"130","author":"Sullivan","year":"2021","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.ajem.2022.05.013_bb0035","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ajem.2021.08.071","article-title":"Tele-buprenorphine for emergency department overdose visit follow up and treatment initiation","volume":"50","author":"Wightman","year":"2021","journal-title":"Am J Emerg Med"},{"issue":"6","key":"10.1016\/j.ajem.2022.05.013_bb0040","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.annemergmed.2021.05.024","article-title":"Rapid adoption of low-threshold buprenorphine treatment at California emergency departments participating in the CA bridge program","volume":"78","author":"Snyder","year":"2021","journal-title":"Ann Emerg Med"},{"issue":"6","key":"10.1016\/j.ajem.2022.05.013_bb0045","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.5811\/westjem.2021.6.51306","article-title":"Healthcare use after buprenorphine prescription in a community emergency department: a cohort study","volume":"22","author":"Le","year":"2022","journal-title":"West J Emerg Med"},{"issue":"3","key":"10.1016\/j.ajem.2022.05.013_bb0050","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.amepre.2021.02.026","article-title":"Association between buprenorphine for opioid use disorder and mortality risk","volume":"61","author":"Vakkalanka","year":"2021","journal-title":"Am J Prev Med"},{"issue":"8","key":"10.1016\/j.ajem.2022.05.013_bb0055","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/add.14188","article-title":"The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom","volume":"113","author":"Hickman","year":"2018","journal-title":"Addiction."},{"issue":"5","key":"10.1016\/j.ajem.2022.05.013_bb0060","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.annemergmed.2018.11.032","article-title":"Managing opioid withdrawal in the emergency department with buprenorphine","volume":"73","author":"Herring","year":"2019","journal-title":"Ann Emerg Med"},{"issue":"3","key":"10.1016\/j.ajem.2022.05.013_bb0065","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.annemergmed.2021.04.023","article-title":"Consensus recommendations on the treatment of opioid use disorder in the emergency department","volume":"78","author":"Hawk","year":"2021","journal-title":"Ann Emerg Med"},{"issue":"3","key":"10.1016\/j.ajem.2022.05.013_bb0070","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jemermed.2019.12.034","article-title":"Management of Opioid use Disorder in the emergency department: a white paper prepared for the American Academy of emergency medicine","volume":"58","author":"Strayer","year":"2020","journal-title":"J Emerg Med"},{"issue":"3","key":"10.1016\/j.ajem.2022.05.013_bb0075","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s13181-019-00712-3","article-title":"ACMT position statement: buprenorphine Administration in the Emergency Department","volume":"15","author":"Wax","year":"2019","journal-title":"J Med Toxicol"},{"issue":"9","key":"10.1016\/j.ajem.2022.05.013_bb0080","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.ajem.2019.02.025","article-title":"Barriers and facilitators for emergency department initiation of buprenorphine: a physician survey","volume":"37","author":"Lowenstein","year":"2019","journal-title":"Am J Emerg Med"},{"issue":"5","key":"10.1016\/j.ajem.2022.05.013_bb0085","doi-asserted-by":"crossref","first-page":"e204561","DOI":"10.1001\/jamanetworkopen.2020.4561","article-title":"Barriers and facilitators to clinician readiness to provide emergency department-initiated buprenorphine","volume":"3","author":"Hawk","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.ajem.2022.05.013_bb0090","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s40261-021-01032-7","article-title":"The pharmacology of buprenorphine microinduction for opioid use disorder","volume":"41","author":"De Aquino","year":"2021","journal-title":"Clin Drug Investig"},{"issue":"6","key":"10.1016\/j.ajem.2022.05.013_bb0095","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s40263-019-00637-z","article-title":"Buprenorphine treatment for opioid use disorder: an overview","volume":"33","author":"Shulman","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ajem.2022.05.013_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2014.07.035","article-title":"Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: implications for clinical use and policy","volume":"144","author":"Greenwald","year":"2014","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.ajem.2022.05.013_bb0105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jsat.2010.04.001","article-title":"Factors associated with complicated buprenorphine inductions","volume":"39","author":"Whitley","year":"2010","journal-title":"J Subst Abuse Treat"},{"issue":"9","key":"10.1016\/j.ajem.2022.05.013_bb0110","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1080\/15563650.2018.1437921","article-title":"Takotsubo cardiomyopathy associated with buprenorphine precipitated withdrawal","volume":"56","author":"Surmaitis","year":"2018","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.ajem.2022.05.013_bb0115","series-title":"Profound increase in epinephrine concentration in plasma and cardiovascular stimulation after mu-opioid receptor blockade in opioid-addicted patients during barbiturate-induced anesthesia for acute detoxification","author":"Kienbaum","year":"2022"},{"issue":"5","key":"10.1016\/j.ajem.2022.05.013_bb0120","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12012-020-09624-z","article-title":"Recurrent Takotsubo cardiomyopathy associated with opioid withdrawal during buprenorphine induction","volume":"21","author":"Jamshidi","year":"2021","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.ajem.2022.05.013_bb0125","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.drugpo.2019.09.003","article-title":"\u201cEverything is not right anymore\u201d: buprenorphine experiences in an era of illicit fentanyl","volume":"74","author":"Silverstein","year":"2019","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.ajem.2022.05.013_bb0130","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ."},{"issue":"4","key":"10.1016\/j.ajem.2022.05.013_bb0135","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/dar.13228","article-title":"Managing opioid withdrawal precipitated by buprenorphine with buprenorphine","volume":"40","author":"Oakley","year":"2021","journal-title":"Drug Alcohol Rev"},{"issue":"7","key":"10.1016\/j.ajem.2022.05.013_bb0140","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.17128","article-title":"High-Dose buprenorphine induction in the emergency department for treatment of opioid use disorder","volume":"4","author":"Herring","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.ajem.2022.05.013_bb0145","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/emp2.12289","article-title":"Microdosing and standard-dosing take-home buprenorphine from the emergency department: a feasibility study","volume":"1","author":"Moe","year":"2020","journal-title":"J Am Coll Emerg Phys Open"},{"issue":"1","key":"10.1016\/j.ajem.2022.05.013_bb0150","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/ajad.13069","article-title":"Method for successfully inducting individuals who use illicit fentanyl onto buprenorphine\/naloxone","volume":"30","author":"Antoine","year":"2021","journal-title":"Am J Addict"},{"key":"10.1016\/j.ajem.2022.05.013_bb0155","first-page":"1","article-title":"Reddit discussions about buprenorphine associated precipitated withdrawal in the era of fentanyl [published online ahead of print, 2022 Feb 4]","author":"Spadaro","year":"2022","journal-title":"Clin Toxicol (Phila)"},{"issue":"2","key":"10.1016\/j.ajem.2022.05.013_bb0160","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/dar.13394","article-title":"Challenges with buprenorphine inductions in the context of the fentanyl overdose crisis: a case series","volume":"41","author":"Shearer","year":"2022","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.ajem.2022.05.013_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108147","article-title":"Protracted renal clearance of fentanyl in persons with opioid use disorder","volume":"214","author":"Huhn","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.ajem.2022.05.013_bb0170","article-title":"Evidence of Buprenorphine-precipitated withdrawal in persons who use fentanyl [published online ahead of print, 2021 Nov 23]","author":"Varshneya","year":"2021","journal-title":"J Addict Med"},{"key":"10.1016\/j.ajem.2022.05.013_bb0175","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/SAR.S109919","article-title":"Use of microdoses for induction of buprenorphine treatment with overlapping full opioid agonist use: the Bernese method","volume":"7","author":"H\u00e4mmig","year":"2016","journal-title":"Subst Abuse Rehabil"},{"issue":"5","key":"10.1016\/j.ajem.2022.05.013_bb0180","first-page":"E1","article-title":"Buprenorphine macro-dosing induction for OUD in the inpatient setting: a case series. 2021 poster abstracts","volume":"15","author":"Monteiro","year":"2021","journal-title":"J Addict Med"},{"key":"10.1016\/j.ajem.2022.05.013_bb0185","article-title":"Synergistic effect of ketamine and buprenorphine observed in the treatment of buprenorphine precipitated opioid withdrawal in a patient with fentanyl use [published online ahead of print, 2021 Nov 16]","author":"Hailozian","year":"2021","journal-title":"J Addict Med"},{"issue":"5","key":"10.1016\/j.ajem.2022.05.013_bb0190","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/JCP.0000000000000763","article-title":"Naltrexone- or Nalmefene-related buprenorphine withdrawal: treat it with\u2026 more buprenorphine","volume":"37","author":"Lescut","year":"2017","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.ajem.2022.05.013_bb0195","article-title":"A case of unintentional naltrexone-induced opioid withdrawal successfully treated with buprenorphine in an emergency department setting","volume":"52","author":"Santos","year":"2014","journal-title":"Clin Toxicol"},{"issue":"4","key":"10.1016\/j.ajem.2022.05.013_bb0200","first-page":"56","article-title":"Buprenorphine rescue from naltrexone-induced opioid withdrawal during relatively rapid detoxification from high-dose methadone: a novel approach","volume":"5","author":"Urban","year":"2008","journal-title":"Psychiatry (Edgmont)"},{"issue":"2","key":"10.1016\/j.ajem.2022.05.013_bb0205","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/08897077.2019.1573776","article-title":"Rapid transition from methadone to buprenorphine using naltrexone-induced withdrawal: a case report","volume":"40","author":"Ward","year":"2019","journal-title":"Subst Abus"},{"issue":"3","key":"10.1016\/j.ajem.2022.05.013_bb0210","doi-asserted-by":"crossref","first-page":"691.e3","DOI":"10.1016\/j.ajem.2019.09.014","article-title":"Treatment of acute naloxone-precipitated opioid withdrawal with buprenorphine","volume":"38","author":"Chhabra","year":"2020","journal-title":"Am J Emerg Med"},{"issue":"2","key":"10.1016\/j.ajem.2022.05.013_bb0215","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/10903127.2020.1747579","article-title":"Buprenorphine field initiation of ReScue treatment by emergency medical services (Bupe FIRST EMS): a case series","volume":"25","author":"Carroll","year":"2021","journal-title":"Prehosp Emerg Care"},{"key":"10.1016\/j.ajem.2022.05.013_bb0220","article-title":"Rapid transition to buprenorphine in a patient with methadone-related QTc interval prolongation [published online ahead of print, 2021 Dec 3]","author":"Brogdon","year":"2021","journal-title":"J Addict Med"},{"key":"10.1016\/j.ajem.2022.05.013_bb0225","series-title":"A Case of Buprenorphine-Precipitated Withdrawal Managed with High-Dose Buprenorphine Family Practice","author":"Quattlebaum","year":"2021"},{"issue":"2","key":"10.1016\/j.ajem.2022.05.013_bb0230","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jemermed.2019.12.015","article-title":"Opioid withdrawal precipitated by Long-acting antagonists","volume":"58","author":"Kunzler","year":"2020","journal-title":"J Emerg Med"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675722003126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675722003126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:00:31Z","timestamp":1760025631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675722003126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":46,"alternative-id":["S0735675722003126"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2022.05.013","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Buprenorphine precipitated opioid withdrawal: Prevention and management in the ED setting","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2022.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}